Gentium (GENT)
Create an Alert
7.58
-0.17 -2.19%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
Gentium Debt to Equity Ratio:
0.0685 for March 31, 2013Gentium Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.0685 |
| Dec. 31, 2012 | 0.0759 |
| Sept. 30, 2012 | 0.0904 |
| June 30, 2012 | 0.097 |
| March 31, 2012 | 0.1152 |
| Dec. 31, 2011 | 0.1179 |
| Sept. 30, 2011 | 0.1323 |
| June 30, 2011 | 0.1421 |
| March 31, 2011 | 0.1794 |
| Dec. 31, 2010 | 0.221 |
| Sept. 30, 2010 | 0.2777 |
| June 30, 2010 | 0.3223 |
| March 31, 2010 | 0.4628 |
| Dec. 31, 2009 | 0.4783 |
| Sept. 30, 2009 | 0.5267 |
| June 30, 2009 | 0.5041 |
| March 31, 2009 | 0.5588 |
| Dec. 31, 2008 | 0.4415 |
| Sept. 30, 2008 | 0.3661 |
| June 30, 2008 | 0.2753 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
GENT Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Salix Pharmaceuticals | 1.657 |
| Takeda Pharmaceutical | 0.2628 |
| BioTech Medics |
GENT Debt to Equity Ratio Rankings
| Overall |
82nd percentile 3018 of 16782 |
| Sector |
72nd percentile 385 of 1410 in Healthcare |
| Industry |
69th percentile 47 of 152 in Drug Manufacturers - Specialty & Generic |
GENT Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.0685 | Mar 2013 |
| Maximum | 0.5588 | Mar 2009 |
| Average | 0.2727 |
